Trader’s Recap – Johnson & Johnson (NYSE:JNJ) , Twitter (NYSE:TWTR) , PRAA, Repligen (NASDAQ:RGEN) , Lincoln Educational Services (NASDAQ:LINC)

Johnson & Johnson (NYSE:JNJ) today announced that its Board of Directors has approved the repurchase of up to $5 billion of the company’s common stock. Repurchases may be made at management’s discretion from time to time on the open market or through privately negotiated transactions. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. Johnson & … Continue reading Trader’s Recap – Johnson & Johnson (NYSE:JNJ) , Twitter (NYSE:TWTR) , PRAA, Repligen (NASDAQ:RGEN) , Lincoln Educational Services (NASDAQ:LINC)

Chris Lewis07/2207/22

Stocks in Focus – Summer Infant (NASDAQ:SUMR), Ethan Allen Interiors Inc. (NYSE:ETH), Johnson & Johnson (NYSE:JNJ) , Nova Measuring Instruments Ltd. (NASDAQ:NVMI)

After meeting with Summer Infant Inc (NASDAQ:SUMR)’s new CEO, Roth Capital is highly impressed by her strategic vision and operational expertise. The firm thinks the company is poised for growth, and it keeps a Buy rating on the shares. Summer Infant, Inc. (NASDAQ:SUMR) stock performance was 12.25% in last session and finished the day at $3.39. Traded volume was 526.32K shares in the last session … Continue reading Stocks in Focus – Summer Infant (NASDAQ:SUMR), Ethan Allen Interiors Inc. (NYSE:ETH), Johnson & Johnson (NYSE:JNJ) , Nova Measuring Instruments Ltd. (NASDAQ:NVMI)

Mark Doerr07/1407/14

Healthcare Active Movers: Geron Corporation (NASDAQ:GERN), Merck (NYSE:MRK), Valeant Pharmaceuticals (NYSE:VRX), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX)

Geron Corporation (NASDAQ:GERN) was one of the Nasdaq’s most active movers, jumping 23 per cent to $3.20 on heavy volume after the US Food and Drug Administration lifted a partial clinical hold on a study testing its blood cancer drug. Geron Corporation (NASDAQ:GERN) stock performance was 21.15% in last session and finished the day at $3.15. Traded volume was 47.60million shares in the last session … Continue reading Healthcare Active Movers: Geron Corporation (NASDAQ:GERN), Merck (NYSE:MRK), Valeant Pharmaceuticals (NYSE:VRX), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX)

Jayne Crisman06/1306/13

Stocks Touched New Highs: Johnson & Johnson (NYSE:JNJ), Aetna Inc (NYSE:AET), BioDelivery Sciences International (NASDAQ:BDSI), CIGNA Corporation (NYSE:CI), Humana (NYSE:HUM)

The IDIX acquisition deal tantalized ACHN investors largely because all and sundry are aware of the contention that MRK had to face during its acquisition process, with a major research based pharma company, AbbVie Inc (NYSE:ABBV) and another prime name in the healthcare industry – Johnson & Johnson (NYSE:JNJ). Johnson & Johnson (NYSE:JNJ) stock performance was -0.75% in last session and finished the day at … Continue reading Stocks Touched New Highs: Johnson & Johnson (NYSE:JNJ), Aetna Inc (NYSE:AET), BioDelivery Sciences International (NASDAQ:BDSI), CIGNA Corporation (NYSE:CI), Humana (NYSE:HUM)

Kevin Long06/1206/12

Hot Watch List: The Procter & Gamble Company (NYSE:PG), AVX Corporation (NYSE:AVX), Google Inc (NASDAQ:GOOGL), Johnson & Johnson (NYSE:JNJ), Wal-Mart Stores (NYSE:WMT)

The Procter & Gamble Company (NYSE:PG), and brewers AB InBev and Greene King have all launched new products and variants recently, and although their strategies differ, each has similar goals: to achieve greater penetration among current customers or appeal to new ones. The Procter & Gamble Company (NYSE:PG) stock performance was -0.09% in last session and finished the day at $79.86. Traded volume was 5.43million … Continue reading Hot Watch List: The Procter & Gamble Company (NYSE:PG), AVX Corporation (NYSE:AVX), Google Inc (NASDAQ:GOOGL), Johnson & Johnson (NYSE:JNJ), Wal-Mart Stores (NYSE:WMT)

Richard Atkins06/0506/05

FB Nasdaq FB Facebook

Healthcare Active Stocks: Johnson & Johnson (NYSE:JNJ), Endo International (NASDAQ:ENDP), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)

Johnson & Johnson (NYSE: JNJ) has inked a global licensing deal with the privately held Aduro BioTech for developing new therapies to treat prostate cancer. According to the oncology deal, the private company granted Janssen Biotech, a division of Johnson & Johnson, the exclusive license to certain candidates specifically engineered for the treatment of prostate cancer on the basis of Aduro’s proprietary live-attenuated double-deleted (LADD) … Continue reading Healthcare Active Stocks: Johnson & Johnson (NYSE:JNJ), Endo International (NASDAQ:ENDP), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)

John Bellich06/0206/02